Valuation: Boston Scientific Corporation

Market Cap 74.52B 64.56B 60.49B 55.18B 104B 7,108B 105B 711B 278B 3,559B 280B 274B 11,867B P/E 2026 *
19.2x
P/E 2027 * 20x
Enterprise Value 83.24B 72.12B 67.57B 61.63B 116B 7,939B 118B 795B 311B 3,975B 313B 306B 13,255B EV / Sales 2026 *
3.9x
EV / Sales 2027 * 3.58x
Free-Float
82.49%
Yield 2026 *
-
Yield 2027 * -
1 day+0.45%
1 week+7.71%
Current month+10.04%
1 month+14.85%
3 months-4.95%
6 months-30.63%
Current year-46.07%
1 week 49.06
Extreme 49.06
51.74
1 month 42.2
Extreme 42.2
51.74
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
05/08/26 Buy

Director

2,100 0.0001%
04/08/26 Buy

Director

140 0.0000%
03/08/26 Buy

Chief Executive Officer

208,359 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%+7.71%-49.90%+0.76% 74.19B
-0.33%+4.36%+26.31%+10.89% 224B
-0.80%+3.07%+0.03%-19.43% 146B
+0.01%+6.95%-16.09%+31.78% 142B
-0.65%+4.59%+20.95%+17.18% 53.99B
-1.41%-0.54%-15.65%-17.29% 50.85B
-0.84%+5.05%+26.36%+16.85% 42.22B
+0.28%+4.04%+45.75%+42.68% 40.75B
-0.65%+2.90%-2.86%+0.96% 32.86B
+0.52%+0.88%-20.22%+25.93% 32.43B
Average -0.34%+3.90%+1.47%+11.03% 83.86B
Weighted average by Cap. -0.34%+4.41%+2.95%+8.99%

Financials

2026 *2027 *
Net sales 21.37B 18.51B 17.34B 15.82B 29.74B 2,038B 30.2B 204B 79.74B 1,020B 80.22B 78.48B 3,402B 22.34B 19.35B 18.13B 16.54B 31.09B 2,130B 31.57B 213B 83.36B 1,067B 83.87B 82.04B 3,557B
Net income 3.84B 3.33B 3.12B 2.85B 5.35B 367B 5.43B 36.69B 14.34B 184B 14.43B 14.12B 612B 3.74B 3.24B 3.04B 2.77B 5.2B 357B 5.28B 35.7B 13.95B 179B 14.04B 13.73B 595B
Net Debt 8.72B 7.55B 7.08B 6.45B 12.13B 831B 12.32B 83.23B 32.53B 416B 32.73B 32.02B 1,388B 5.45B 4.72B 4.43B 4.04B 7.59B 520B 7.71B 52.05B 20.35B 260B 20.47B 20.02B 868B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
12/08/26 $51.42 +0.45% 20,667,977
11/08/26 $51.19 +1.45% 13,453,112
10/08/26 $50.46 +2.33% 18,994,452
07/08/26 $49.31 +0.02% 11,447,002
06/08/26 $49.30 +3.27% 21,398,972
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
51.42USD
Average target price
62.69USD
Spread / Average Target
+21.92%

Quarterly revenue - Rate of surprise